Mesenchymal stem cells and cardiac repair: principles and practice.

Jozef Bartunek, Atta Behfar, Marc Vanderheyden, William Wijns, Andre Terzic

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Mesenchymal stem cells (MSCs) are cluster of differentiation 34 (CD34)-CD45-negative nonhematopoietic progenitors derived typically from the stromal fraction of the bone marrow. These stem cells display multipotent properties with a demonstrable differentiation capacity along multiple mesodermal lineages. In the setting of myocardial injury, preclinical studies indicate benefit of both autologous and allogeneic transplantation in line with a recognized immunotolerant profile. Initial clinical experience supports the value of mesenchymal stem-cell-based therapy in ischemic cardiomyopathy. Experience is however limited to naïve mesenchymal stem cells, with efforts underway to identify optimal means of enhancing the cardiogenic potential of transplanted cells through guided cardiopoiesis with the ultimate aim of achieving standardized therapy of the ischemic myocardium.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalJournal of cardiovascular translational research
Issue number2
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmaceutical Science
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)


Dive into the research topics of 'Mesenchymal stem cells and cardiac repair: principles and practice.'. Together they form a unique fingerprint.

Cite this